AUDENTES THERAPEUTICS INC's ticker is BOLD and the CUSIP is 05070R104. A total of 70 filers reported holding AUDENTES THERAPEUTICS INC in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $7,581,000 | +252600.0% | 126,695 | +118306.5% | 0.00% | – |
| Q3 2019 | $3,000 | -25.0% | 107 | +13.8% | 0.00% | – |
| Q2 2019 | $4,000 | +100.0% | 94 | +84.3% | 0.00% | – |
| Q1 2019 | $2,000 | +100.0% | 51 | 0.0% | 0.00% | – |
| Q4 2018 | $1,000 | -97.1% | 51 | -94.1% | 0.00% | – |
| Q3 2018 | $34,000 | +466.7% | 865 | +424.2% | 0.00% | – |
| Q2 2018 | $6,000 | +200.0% | 165 | +211.3% | 0.00% | – |
| Q1 2018 | $2,000 | -33.3% | 53 | -23.2% | 0.00% | – |
| Q4 2017 | $3,000 | -92.5% | 69 | -95.1% | 0.00% | – |
| Q3 2017 | $40,000 | +3900.0% | 1,419 | +2527.8% | 0.00% | – |
| Q2 2017 | $1,000 | -80.0% | 54 | -79.9% | 0.00% | – |
| Q1 2017 | $5,000 | 0.0% | 268 | -0.7% | 0.00% | – |
| Q4 2016 | $5,000 | +150.0% | 270 | +170.0% | 0.00% | – |
| Q3 2016 | $2,000 | – | 100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEXTHERA CAPITAL LP | 294,013 | $11,131,000 | 9.27% |
| GREAT POINT PARTNERS LLC | 1,922,937 | $72,802,000,000 | 8.08% |
| Versant Venture Management, LLC | 553,916 | $20,971,260,000 | 6.11% |
| Foresite Capital Management III, LLC | 315,331 | $11,938,000 | 3.92% |
| Casdin Capital, LLC | 965,000 | $36,534,900,000 | 3.42% |
| Sofinnova Investments, Inc. | 933,640 | $35,348,000 | 3.25% |
| Opaleye Management Inc. | 280,000 | $10,601,000 | 3.23% |
| Redmile Group, LLC | 2,972,167 | $112,526,000 | 3.18% |
| PFM Health Sciences, LP | 3,228,679 | $122,238,000 | 2.32% |
| Eversept Partners, LP | 159,526 | $6,039,654 | 1.69% |